{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:03:21Z","timestamp":1785517401759,"version":"3.56.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res Commun"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11259-024-10522-w","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T07:02:42Z","timestamp":1725001362000},"page":"3517-3531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mesenchymal stem cell therapy in veterinary ophthalmology: clinical evidence and prospects"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1040-3746","authenticated-orcid":false,"given":"Khan","family":"Sharun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Amitha","family":"Banu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Alifsha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laith","family":"Abualigah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Pawde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeep","family":"Dhama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"10522_CR1","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815\u20131822. https:\/\/doi.org\/10.1182\/blood-2004-04-1559","journal-title":"Blood"},{"key":"10522_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/pharmaceutics14020381","volume":"14","author":"R Alvites","year":"2022","unstructured":"Alvites R, Branquinho M, Sousa AC et al (2022) Mesenchymal Stem\/Stromal cells and their paracrine activity-immunomodulation mechanisms and how to influence the therapeutic potential. Pharmaceutics 14:381. https:\/\/doi.org\/10.3390\/pharmaceutics14020381","journal-title":"Pharmaceutics"},{"key":"10522_CR3","volume-title":"Treatment for Canine Corneal Ulcer using Adipose Tissue-","author":"P Arantes-Tsuzuki","year":"2019","unstructured":"Arantes-Tsuzuki P, de Mazzonetto M, Turco PC (2019) Treatment for Canine Corneal Ulcer using Adipose Tissue-. derived Mesenchymal Stem Cell Therapy - Case Report"},{"key":"10522_CR4","first-page":"1009","volume":"60","author":"J Bajwa","year":"2019","unstructured":"Bajwa J (2019) Feline indolent ulcers and their significance. Can Vet J 60:1009\u20131011","journal-title":"Can Vet J"},{"key":"10522_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.21037\/sci-2022-025","volume":"9","author":"DS Baranovskii","year":"2022","unstructured":"Baranovskii DS, Klabukov ID, Arguchinskaya NV et al (2022) Adverse events, side effects and complications in mesenchymal stromal cell-based therapies. Stem Cell Investig 9:7. https:\/\/doi.org\/10.21037\/sci-2022-025","journal-title":"Stem Cell Investig"},{"key":"10522_CR6","doi-asserted-by":"publisher","first-page":"107709","DOI":"10.1016\/j.exer.2019.107709","volume":"186","author":"B Barrientez","year":"2019","unstructured":"Barrientez B, Nicholas SE, Whelchel A et al (2019) Corneal Injury: clinical and molecular aspects. Exp Eye Res 186:107709. https:\/\/doi.org\/10.1016\/j.exer.2019.107709","journal-title":"Exp Eye Res"},{"key":"10522_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/sctm.20-0118","volume":"10","author":"LJ Beeken","year":"2020","unstructured":"Beeken LJ, Ting DSJ, Sidney LE (2020) Potential of mesenchymal stem cells as topical immunomodulatory cell therapies for ocular surface inflammatory disorders. Stem Cells Transl Med 10:39\u201349. https:\/\/doi.org\/10.1002\/sctm.20-0118","journal-title":"Stem Cells Transl Med"},{"key":"10522_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3727\/215517916X693366","volume":"8","author":"MKW Bittencourt","year":"2016","unstructured":"Bittencourt MKW, Barros MA, Martins JFP et al (2016) Allogeneic mesenchymal stem cell transplantation in Dogs with Keratoconjunctivitis Sicca. Cell Med 8:63\u201377. https:\/\/doi.org\/10.3727\/215517916X693366","journal-title":"Cell Med"},{"key":"10522_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.vetimm.2017.04.002","volume":"187","author":"BK Braus","year":"2017","unstructured":"Braus BK, Miller I, Kummer S et al (2017) Investigation of corneal autoantibodies in horses with immune mediated keratitis (IMMK). Vet Immunol Immunopathol 187:48\u201354. https:\/\/doi.org\/10.1016\/j.vetimm.2017.04.002","journal-title":"Vet Immunol Immunopathol"},{"key":"10522_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/vop.12171","volume":"18","author":"C Busse","year":"2015","unstructured":"Busse C, Hartley C, Kafarnik C, Pivetta M (2015) Ocular alkaline injury in four dogs - presentation, treatment, and follow-up - a case series. Vet Ophthalmol 18:127\u2013134. https:\/\/doi.org\/10.1111\/vop.12171","journal-title":"Vet Ophthalmol"},{"key":"10522_CR11","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3390\/pharmaceutics13091483","volume":"13","author":"M Calonge","year":"2021","unstructured":"Calonge M, Nieto-Miguel T, de la Mata A et al (2021) Goals and challenges of stem cell-based therapy for corneal blindness due to limbal deficiency. Pharmaceutics 13:1483. https:\/\/doi.org\/10.3390\/pharmaceutics13091483","journal-title":"Pharmaceutics"},{"key":"10522_CR12","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcb.20886","volume":"98","author":"AI Caplan","year":"2006","unstructured":"Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076\u20131084. https:\/\/doi.org\/10.1002\/jcb.20886","journal-title":"J Cell Biochem"},{"key":"10522_CR13","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41433-018-0061-z","volume":"32","author":"V Chichagova","year":"2018","unstructured":"Chichagova V, Hallam D, Collin J et al (2018) Cellular regeneration strategies for macular degeneration: past, present and future. Eye 32:946\u2013971. https:\/\/doi.org\/10.1038\/s41433-018-0061-z","journal-title":"Eye"},{"key":"10522_CR14","doi-asserted-by":"publisher","first-page":"12594","DOI":"10.3390\/ijms241612594","volume":"24","author":"B Chouaib","year":"2023","unstructured":"Chouaib B, Haack-S\u00f8rensen M, Chaubron F et al (2023) Towards the standardization of mesenchymal stem cell secretome-derived product manufacturing for tissue regeneration. Int J Mol Sci 24:12594. https:\/\/doi.org\/10.3390\/ijms241612594","journal-title":"Int J Mol Sci"},{"key":"10522_CR15","first-page":"608","volume":"32","author":"R Christmas","year":"1991","unstructured":"Christmas R (1991) Management of chemical burns of the canine cornea. Can Vet J 32:608\u2013612","journal-title":"Can Vet J"},{"key":"10522_CR16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s12015-017-9750-4","volume":"13","author":"A Cislo-Pakuluk","year":"2017","unstructured":"Cislo-Pakuluk A, Marycz K (2017) A Promising Tool in retina regeneration: current perspectives and challenges when using mesenchymal progenitor stem cells in Veterinary and Human Ophthalmological Applications. Stem Cell Rev Rep 13:598\u2013602. https:\/\/doi.org\/10.1007\/s12015-017-9750-4","journal-title":"Stem Cell Rev Rep"},{"key":"10522_CR17","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3390\/jcm8040510","volume":"8","author":"A Cislo-Pakuluk","year":"2019","unstructured":"Cislo-Pakuluk A, Smieszek A, Kucharczyk N et al (2019) Intra-vitreal Administration of microvesicles derived from human adipose-derived multipotent stromal cells improves retinal functionality in dogs with retinal degeneration. J Clin Med 8:510. https:\/\/doi.org\/10.3390\/jcm8040510","journal-title":"J Clin Med"},{"key":"10522_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.proeng.2015.07.004","volume":"110","author":"CJ Connon","year":"2015","unstructured":"Connon CJ (2015) Approaches to corneal tissue engineering: top-down or bottom-up? Procedia Eng 110:15\u201320. https:\/\/doi.org\/10.1016\/j.proeng.2015.07.004","journal-title":"Procedia Eng"},{"key":"10522_CR19","doi-asserted-by":"publisher","first-page":"100107","DOI":"10.1016\/j.mtbio.2021.100107","volume":"10","author":"N Contessi Negrini","year":"2021","unstructured":"Contessi Negrini N, Angelova Volponi A, Higgins CA et al (2021) Scaffold-based developmental tissue engineering strategies for ectodermal organ regeneration. Mater Today Bio 10:100107. https:\/\/doi.org\/10.1016\/j.mtbio.2021.100107","journal-title":"Mater Today Bio"},{"key":"10522_CR20","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.3390\/ijms23116356","volume":"23","author":"VJ Costela-Ruiz","year":"2022","unstructured":"Costela-Ruiz VJ, Melguizo-Rodr\u00edguez L, Bellotti C et al (2022) Different sources of mesenchymal stem cells for tissue regeneration: a guide to identifying the most favorable one in Orthopedics and Dentistry Applications. Int J Mol Sci 23:6356. https:\/\/doi.org\/10.3390\/ijms23116356","journal-title":"Int J Mol Sci"},{"key":"10522_CR21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/vop.12641","volume":"22","author":"AB Davis","year":"2019","unstructured":"Davis AB, Schnabel LV, Gilger BC (2019) Subconjunctival bone marrow-derived mesenchymal stem cell therapy as a novel treatment alternative for equine immune-mediated keratitis: a case series. Vet Ophthalmol 22:674\u2013682. https:\/\/doi.org\/10.1111\/vop.12641","journal-title":"Vet Ophthalmol"},{"key":"10522_CR22","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3390\/ijms20071784","volume":"20","author":"SSL Ding","year":"2019","unstructured":"Ding SSL, Subbiah SK, Khan MSA et al (2019) Empowering mesenchymal stem cells for ocular degenerative disorders. Int J Mol Sci 20:1784. https:\/\/doi.org\/10.3390\/ijms20071784","journal-title":"Int J Mol Sci"},{"key":"10522_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2147\/VMRR.S66705","volume":"6","author":"PL Dodi","year":"2015","unstructured":"Dodi PL (2015) Immune-mediated keratoconjunctivitis sicca in dogs: current perspectives on management. Vet Med Auckl NZ 6:341\u2013347. https:\/\/doi.org\/10.2147\/VMRR.S66705","journal-title":"Vet Med Auckl NZ"},{"key":"10522_CR24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2478\/pjvs-2014-0082","volume":"17","author":"Z Drahovska","year":"2014","unstructured":"Drahovska Z, Balicki I, Trbolova A et al (2014) A retrospective study of the occurrence of chronic superficial keratitis in 308 German shepherd dogs: 1999\u20132010. Pol J Vet Sci 17:543\u2013546. https:\/\/doi.org\/10.2478\/pjvs-2014-0082","journal-title":"Pol J Vet Sci"},{"key":"10522_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.actbio.2021.03.069","volume":"133","author":"CM Dunn","year":"2021","unstructured":"Dunn CM, Kameishi S, Grainger DW, Okano T (2021) Strategies to address mesenchymal stem\/stromal cell heterogeneity in immunomodulatory profiles to improve cell-based therapies. Acta Biomater 133:114\u2013125. https:\/\/doi.org\/10.1016\/j.actbio.2021.03.069","journal-title":"Acta Biomater"},{"key":"10522_CR26","doi-asserted-by":"publisher","unstructured":"Enriquez-Ochoa D, Robles-Ovalle P, Mayolo-Deloisa K, Brunck MEG (2020) Immobilization of growth factors for cell therapy manufacturing. Front Bioeng Biotechnol 8. https:\/\/doi.org\/10.3389\/fbioe.2020.00620","DOI":"10.3389\/fbioe.2020.00620"},{"key":"10522_CR27","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jtcme.2019.04.006","volume":"10","author":"MSA Falc\u00e3o","year":"2019","unstructured":"Falc\u00e3o MSA, Brunel H dos SS, Peixer MAS et al (2019) Effect of allogeneic mesenchymal stem cells (MSCs) on corneal wound healing in dogs. J Tradit Complement Med 10:440\u2013445. https:\/\/doi.org\/10.1016\/j.jtcme.2019.04.006","journal-title":"J Tradit Complement Med"},{"key":"10522_CR28","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00018-020-03454-6","volume":"77","author":"X-L Fan","year":"2020","unstructured":"Fan X-L, Zhang Y, Li X, Fu Q-L (2020) Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell Mol Life Sci CMLS 77:2771\u20132794. https:\/\/doi.org\/10.1007\/s00018-020-03454-6","journal-title":"Cell Mol Life Sci CMLS"},{"key":"10522_CR29","doi-asserted-by":"publisher","first-page":"112212","DOI":"10.1016\/j.msec.2021.112212","volume":"127","author":"G Fang","year":"2021","unstructured":"Fang G, Yang X, Wang Q et al (2021) Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases. Mater Sci Eng C Mater Biol Appl 127:112212. https:\/\/doi.org\/10.1016\/j.msec.2021.112212","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10522_CR30","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"J Galipeau","year":"2018","unstructured":"Galipeau J, Sens\u00e9b\u00e9 L (2018) Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell 22:824\u2013833. https:\/\/doi.org\/10.1016\/j.stem.2018.05.004","journal-title":"Cell Stem Cell"},{"key":"10522_CR31","doi-asserted-by":"publisher","first-page":"ajvr.22.08.0145","DOI":"10.2460\/ajvr.22.08.0145","volume":"83","author":"BC Gilger","year":"2022","unstructured":"Gilger BC (2022) Developing advanced therapeutics through the study of naturally occurring immune-mediated ocular disease in domestic animals. Am J Vet Res 83:ajvr.22.08.0145. https:\/\/doi.org\/10.2460\/ajvr.22.08.0145","journal-title":"Am J Vet Res"},{"key":"10522_CR32","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.cveq.2023.06.004","volume":"39","author":"BC Gilger","year":"2023","unstructured":"Gilger BC (2023) Use of Biologics and Stem cells in equine Ophthalmology. Vet Clin North Am Equine Pract 39:541\u2013552. https:\/\/doi.org\/10.1016\/j.cveq.2023.06.004","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10522_CR33","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/vop.12740","volume":"23","author":"S Gogova","year":"2020","unstructured":"Gogova S, Leiva M, Ortill\u00e9s \u00c1 et al (2020) Corneoconjunctival transposition for the treatment of deep stromal to full-thickness corneal defects in dogs: a multicentric retrospective study of 100 cases (2012\u20132018). Vet Ophthalmol 23:450\u2013459. https:\/\/doi.org\/10.1111\/vop.12740","journal-title":"Vet Ophthalmol"},{"key":"10522_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/978-981-19-3277-9_13","volume-title":"Therapeutic applications of mesenchymal stem cells in Veterinary Medicine","author":"MB Gugjoo","year":"2022","unstructured":"Gugjoo MB (2022) Mesenchymal stem cells therapeutic applications in Eye and Adnexa ailments. In: Gugjoo MB (ed) Therapeutic applications of mesenchymal stem cells in Veterinary Medicine. Springer Nature, Singapore, pp 391\u2013408"},{"key":"10522_CR35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","volume":"7","author":"Y Han","year":"2022","unstructured":"Han Y, Yang J, Fang J et al (2022) The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal Transduct Target Ther 7:92. https:\/\/doi.org\/10.1038\/s41392-022-00932-0","journal-title":"Signal Transduct Target Ther"},{"key":"10522_CR36","first-page":"1034","volume":"46","author":"A Hodges","year":"2005","unstructured":"Hodges A (2005) Eosinophilic keratitis and keratoconjunctivitis in a 7-year-old domestic shorthaired cat. Can Vet J 46:1034\u20131035","journal-title":"Can Vet J"},{"key":"10522_CR37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.exer.2007.04.007","volume":"85","author":"Y Inoue","year":"2007","unstructured":"Inoue Y, Iriyama A, Ueno S et al (2007) Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. Exp Eye Res 85:234\u2013241. https:\/\/doi.org\/10.1016\/j.exer.2007.04.007","journal-title":"Exp Eye Res"},{"key":"10522_CR38","doi-asserted-by":"publisher","first-page":"897150","DOI":"10.3389\/fvets.2022.897150","volume":"9","author":"A Ivanovska","year":"2022","unstructured":"Ivanovska A, Wang M, Arshaghi TE et al (2022) Manufacturing Mesenchymal stromal cells for the treatment of Osteoarthritis in Canine patients: challenges and recommendations. Front Vet Sci 9:897150. https:\/\/doi.org\/10.3389\/fvets.2022.897150","journal-title":"Front Vet Sci"},{"key":"10522_CR39","doi-asserted-by":"publisher","first-page":"e12712","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang W, Xu J (2020) Immune modulation by mesenchymal stem cells. Cell Prolif 53:e12712. https:\/\/doi.org\/10.1111\/cpr.12712","journal-title":"Cell Prolif"},{"key":"10522_CR40","doi-asserted-by":"publisher","first-page":"963689722113381","DOI":"10.1177\/09636897221133818","volume":"31","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Lin S, Gao Y (2022) Mesenchymal stromal cell-based therapy for Dry Eye: current status and future perspectives. Cell Transpl 31:9636897221133818. https:\/\/doi.org\/10.1177\/09636897221133818","journal-title":"Cell Transpl"},{"key":"10522_CR41","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/s0195-5616(90)50052-2","volume":"20","author":"RL Kaswan","year":"1990","unstructured":"Kaswan RL, Salisbury MA (1990) A new perspective on canine keratoconjunctivitis sicca. Treatment with ophthalmic cyclosporine. Vet Clin North Am Small Anim Pract 20:583\u2013613. https:\/\/doi.org\/10.1016\/s0195-5616(90)50052-2","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10522_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13287-018-0791-7","volume":"9","author":"S Keshtkar","year":"2018","unstructured":"Keshtkar S, Azarpira N, Ghahremani MH (2018) Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther 9:63. https:\/\/doi.org\/10.1186\/s13287-018-0791-7","journal-title":"Stem Cell Res Ther"},{"key":"10522_CR43","doi-asserted-by":"publisher","first-page":"157","DOI":"10.14405\/kjvr.2012.52.3.157","volume":"52","author":"J-W Kim","year":"2012","unstructured":"Kim J-W, Lee S-Y, Park H-M (2012) Safety and outcomes of subconjunctival allogenic mesenchymal stem cell transplantation in canine experimental corneal defects. Korean J Vet Res 52:157\u2013162. https:\/\/doi.org\/10.14405\/kjvr.2012.52.3.157","journal-title":"Korean J Vet Res"},{"key":"10522_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4142\/jvs.2016.17.1.123","volume":"17","author":"Y Kim","year":"2016","unstructured":"Kim Y, Lee SH, Kim WH, Kweon O-K (2016) Transplantation of adipose derived mesenchymal stem cells for acute thoracolumbar disc disease with no deep pain perception in dogs. J Vet Sci 17:123\u2013126. https:\/\/doi.org\/10.4142\/jvs.2016.17.1.123","journal-title":"J Vet Sci"},{"key":"10522_CR45","first-page":"155","volume":"50","author":"TG Koch","year":"2009","unstructured":"Koch TG, Berg LC, Betts DH (2009) Current and future regenerative medicine \u2014 principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine. Can Vet J 50:155\u2013165","journal-title":"Can Vet J"},{"key":"10522_CR46","doi-asserted-by":"publisher","first-page":"308ps21","DOI":"10.1126\/scitranslmed.aaa9116","volume":"7","author":"A Kol","year":"2015","unstructured":"Kol A, Arzi B, Athanasiou KA et al (2015) Companion animals: translational scientist\u2019s new best friends. Sci Transl Med 7:308ps21. https:\/\/doi.org\/10.1126\/scitranslmed.aaa9116","journal-title":"Sci Transl Med"},{"key":"10522_CR47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13287-015-0050-0","volume":"6","author":"A Kol","year":"2015","unstructured":"Kol A, Wood JA, Carrade Holt DD et al (2015) Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses. Stem Cell Res Ther 6:73. https:\/\/doi.org\/10.1186\/s13287-015-0050-0","journal-title":"Stem Cell Res Ther"},{"key":"10522_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15283\/ijsc.2008.1.1.1","volume":"1","author":"A Kurtz","year":"2008","unstructured":"Kurtz A (2008) Mesenchymal stem cell delivery routes and fate. Int J Stem Cells 1:1\u20137","journal-title":"Int J Stem Cells"},{"key":"10522_CR49","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bbmt.2013.11.001","volume":"20","author":"J Kurtzberg","year":"2014","unstructured":"Kurtzberg J, Prockop S, Teira P et al (2014) Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl 20:229\u2013235. https:\/\/doi.org\/10.1016\/j.bbmt.2013.11.001","journal-title":"Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl"},{"key":"10522_CR50","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/vop.12076","volume":"17","author":"M Lassaline-Utter","year":"2014","unstructured":"Lassaline-Utter M, Miller C, Wotman KL (2014) Eosinophilic keratitis in 46 eyes of 27 horses in the Mid-atlantic United States (2008\u20132012). Vet Ophthalmol 17:311\u2013320. https:\/\/doi.org\/10.1111\/vop.12076","journal-title":"Vet Ophthalmol"},{"key":"10522_CR51","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13578-021-00698-y","volume":"11","author":"C Li","year":"2021","unstructured":"Li C, Zhao H, Cheng L, Wang B (2021) Allogeneic vs. autologous mesenchymal stem\/stromal cells in their medication practice. Cell Biosci 11:187. https:\/\/doi.org\/10.1186\/s13578-021-00698-y","journal-title":"Cell Biosci"},{"key":"10522_CR52","doi-asserted-by":"publisher","first-page":"9428176","DOI":"10.1155\/2017\/9428176","volume":"2017","author":"T-C Lin","year":"2017","unstructured":"Lin T-C, Seiler MJ, Zhu D et al (2017) Assessment of Safety and Functional Efficacy of Stem Cell-based therapeutic approaches using retinal degenerative animal models. Stem Cells Int 2017:9428176. https:\/\/doi.org\/10.1155\/2017\/9428176","journal-title":"Stem Cells Int"},{"key":"10522_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000290897","volume":"37","author":"U Lindner","year":"2010","unstructured":"Lindner U, Kramer J, Rohwedel J, Schlenke P (2010) Mesenchymal stem or stromal cells: toward a better understanding of their Biology? Transfus Med Hemotherapy 37:75\u201383. https:\/\/doi.org\/10.1159\/000290897","journal-title":"Transfus Med Hemotherapy"},{"key":"10522_CR54","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.3390\/ijms20122853","volume":"20","author":"H Mansoor","year":"2019","unstructured":"Mansoor H, Ong HS, Riau AK et al (2019) Current trends and Future Perspective of Mesenchymal Stem cells and exosomes in corneal diseases. Int J Mol Sci 20:2853. https:\/\/doi.org\/10.3390\/ijms20122853","journal-title":"Int J Mol Sci"},{"key":"10522_CR55","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/jcp.22953","volume":"227","author":"G Marfe","year":"2012","unstructured":"Marfe G, Massaro-Giordano M, Ranalli M et al (2012) Blood derived stem cells: an ameliorative therapy in veterinary ophthalmology. J Cell Physiol 227:1250\u20131256. https:\/\/doi.org\/10.1002\/jcp.22953","journal-title":"J Cell Physiol"},{"key":"10522_CR56","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/vop.12907","volume":"24","author":"V Mezzadri","year":"2021","unstructured":"Mezzadri V, Crotti A, Nardi S, Barsotti G (2021) Surgical treatment of canine and feline descemetoceles, deep and perforated corneal ulcers with autologous buccal mucous membrane grafts. Vet Ophthalmol 24:599\u2013609. https:\/\/doi.org\/10.1111\/vop.12907","journal-title":"Vet Ophthalmol"},{"key":"10522_CR57","doi-asserted-by":"publisher","first-page":"637725","DOI":"10.3389\/fcell.2021.637725","volume":"9","author":"L M\u00fcller","year":"2021","unstructured":"M\u00fcller L, Tunger A, Wobus M et al (2021) Immunomodulatory properties of mesenchymal stromal cells: an update. Front Cell Dev Biol 9:637725. https:\/\/doi.org\/10.3389\/fcell.2021.637725","journal-title":"Front Cell Dev Biol"},{"key":"10522_CR58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/bioengineering9030111","volume":"9","author":"S Muthu","year":"2022","unstructured":"Muthu S, Jeyaraman M, Kotner MB et al (2022) Evolution of mesenchymal stem cell therapy as an Advanced Therapeutic Medicinal product (ATMP)-An Indian perspective. Bioeng Basel Switz 9:111. https:\/\/doi.org\/10.3390\/bioengineering9030111","journal-title":"Bioeng Basel Switz"},{"key":"10522_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/vop.13175","author":"F Narinx","year":"2023","unstructured":"Narinx F, Sauvage A, Ceusters J et al (2023) Subconjunctival autologous muscle-derived mesenchymal stem cell therapy: a novel, minimally invasive approach for treating equine immune-mediated keratitis. Vet Ophthalmol. https:\/\/doi.org\/10.1111\/vop.13175","journal-title":"Vet Ophthalmol"},{"key":"10522_CR60","doi-asserted-by":"publisher","first-page":"900","DOI":"10.5603\/FM.a2021.0085","volume":"81","author":"WA Nasr El-Din","year":"2022","unstructured":"Nasr El-Din WA, Nooreldin N, Essawy AS (2022) The potential therapeutic efficacy of intravenous versus subconjunctival mesenchymal stem cells on experimentally ultraviolet-induced corneal injury in adult male albino rats. Folia Morphol 81:900\u2013916. https:\/\/doi.org\/10.5603\/FM.a2021.0085","journal-title":"Folia Morphol"},{"key":"10522_CR61","first-page":"31","volume":"64","author":"RV Novaes","year":"2023","unstructured":"Novaes RV, Hill JEBT, Hill ABT (2023) Efficacious cellular therapy of descemetocele in a dog. Can Vet J Rev Veterinaire Can 64:31\u201333","journal-title":"Can Vet J Rev Veterinaire Can"},{"key":"10522_CR62","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40575-017-0045-5","volume":"4","author":"DG O\u2019Neill","year":"2017","unstructured":"O\u2019Neill DG, Lee MM, Brodbelt DC et al (2017) Corneal ulcerative disease in dogs under primary veterinary care in England: epidemiology and clinical management. Canine Genet Epidemiol 4:5. https:\/\/doi.org\/10.1186\/s40575-017-0045-5","journal-title":"Canine Genet Epidemiol"},{"key":"10522_CR63","doi-asserted-by":"publisher","first-page":"349","DOI":"10.24099\/vet.arhiv.0951","volume":"91","author":"BB Ozgermen","year":"2021","unstructured":"Ozgermen BB, Can P, Sancak \u0130 et al (2021) Transplantation of limbal derived MSCs grown on contact lenses in dogs with dry eye syndrome-can stem cells help? Vet Arh 91:349\u2013358","journal-title":"Vet Arh"},{"key":"10522_CR64","first-page":"1","volume":"7","author":"P Palafox-Herrera","year":"2023","unstructured":"Palafox-Herrera P, Ortiz-Avilez YN, Ruelas-Aviles R et al (2023) Use of mesenchymal stem cells in corneal ulcers in dogs: a Case Report. Mathews J Vet Sci 7:1\u20135","journal-title":"Mathews J Vet Sci"},{"key":"10522_CR65","doi-asserted-by":"publisher","first-page":"274","DOI":"10.5455\/vetworld.2013.274-276","volume":"6","author":"T Paramasivam","year":"2013","unstructured":"Paramasivam T, Zama M, Pathak R et al (2013) A retrospective study of ocular occurences in domestic animals: 799 cases. Vet World 6:274. https:\/\/doi.org\/10.5455\/vetworld.2013.274-276","journal-title":"Vet World"},{"key":"10522_CR66","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.jcyt.2013.06.009","volume":"15","author":"SA Park","year":"2013","unstructured":"Park SA, Reilly CM, Wood JA et al (2013) Safety and immunomodulatory effects of allogeneic canine adipose-derived mesenchymal stromal cells transplanted into the region of the lacrimal gland, the gland of the third eyelid and the knee joint. Cytotherapy 15:1498\u20131510. https:\/\/doi.org\/10.1016\/j.jcyt.2013.06.009","journal-title":"Cytotherapy"},{"key":"10522_CR67","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2460\/ajvr.73.7.1067","volume":"73","author":"DO Pate","year":"2012","unstructured":"Pate DO, Clode AB, Olivry T et al (2012) Immunohistochemical and immunopathologic characterization of superficial stromal immune-mediated keratitis in horses. Am J Vet Res 73:1067\u20131073. https:\/\/doi.org\/10.2460\/ajvr.73.7.1067","journal-title":"Am J Vet Res"},{"key":"10522_CR68","doi-asserted-by":"publisher","first-page":"744","DOI":"10.5455\/OVJ.2022.v12.i5.20","volume":"12","author":"AL Pereira","year":"2022","unstructured":"Pereira AL, Bittencourt MKW, Barros MA et al (2022) Subconjunctival use of allogeneic mesenchymal stem cells to treat chronic superficial keratitis in German shepherd dogs: pilot study. Open Vet J 12:744\u2013753. https:\/\/doi.org\/10.5455\/OVJ.2022.v12.i5.20","journal-title":"Open Vet J"},{"key":"10522_CR69","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.tvjl.2015.08.003","volume":"206","author":"EM P\u00e9rez-Merino","year":"2015","unstructured":"P\u00e9rez-Merino EM, Us\u00f3n-Casa\u00fas JM, Zaragoza-Bayle C et al (2015) Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: clinical and laboratory outcomes. Vet J 206:385\u2013390. https:\/\/doi.org\/10.1016\/j.tvjl.2015.08.003","journal-title":"Vet J"},{"key":"10522_CR70","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3390\/ani14091363","volume":"14","author":"RA Picazo","year":"2024","unstructured":"Picazo RA, Rojo C, Rodriguez-Quiros J, Gonz\u00e1lez-Gil A (2024) Current advances in mesenchymal stem cell therapies Applied to wounds and skin, Eye, and neuromuscular diseases in Companion animals. Anim Open Access J MDPI 14:1363. https:\/\/doi.org\/10.3390\/ani14091363","journal-title":"Anim Open Access J MDPI"},{"key":"10522_CR71","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.bbmt.2010.04.014","volume":"17","author":"VK Prasad","year":"2011","unstructured":"Prasad VK, Lucas KG, Kleiner GI et al (2011) Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal\u2122) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl 17:534\u2013541. https:\/\/doi.org\/10.1016\/j.bbmt.2010.04.014","journal-title":"Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl"},{"key":"10522_CR72","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/scrt198","volume":"4","author":"JM Quimby","year":"2013","unstructured":"Quimby JM, Webb TL, Habenicht LM, Dow SW (2013) Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies. Stem Cell Res Ther 4:48. https:\/\/doi.org\/10.1186\/scrt198","journal-title":"Stem Cell Res Ther"},{"key":"10522_CR73","volume-title":"Cell therapy using amniotic membrane stem cell to treat keratoconjunctivitis Sicca in dogs","author":"S Ramos","year":"2016","unstructured":"Ramos S (2016) Cell therapy using amniotic membrane stem cell to treat keratoconjunctivitis Sicca in dogs. Faculdade de Medicina Veterin\u00e1ria e Zootecnia, Universidade de S\u00e3o Paulo"},{"key":"10522_CR74","doi-asserted-by":"publisher","first-page":"101525","DOI":"10.1016\/j.scr.2019.101525","volume":"39","author":"MR Sgrignoli","year":"2019","unstructured":"Sgrignoli MR, Silva DA, Nascimento FF et al (2019) Reduction in the inflammatory markers CD4, IL-1, IL-6 and TNF\u03b1 in dogs with keratoconjunctivitis sicca treated topically with mesenchymal stem cells. Stem Cell Res 39:101525. https:\/\/doi.org\/10.1016\/j.scr.2019.101525","journal-title":"Stem Cell Res"},{"key":"10522_CR75","first-page":"57","volume":"3","author":"A Shadmani","year":"2014","unstructured":"Shadmani A, Kazemi K, Khalili MR, Eghtedari M (2014) Omental transposition in treatment of severe ocular surface alkaline burn: an experimental study. Med Hypothesis Discov Innov Ophthalmol J 3:57\u201361","journal-title":"Med Hypothesis Discov Innov Ophthalmol J"},{"key":"10522_CR76","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.bioactmat.2020.08.014","volume":"6","author":"F Shang","year":"2021","unstructured":"Shang F, Yu Y, Liu S et al (2021) Advancing application of mesenchymal stem cell-based bone tissue regeneration. Bioact Mater 6:666\u2013683. https:\/\/doi.org\/10.1016\/j.bioactmat.2020.08.014","journal-title":"Bioact Mater"},{"key":"10522_CR77","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/2772270816666211220152218","volume":"15","author":"K Sharun","year":"2022","unstructured":"Sharun K, Dhama K, Jambagi K et al (2022) Cell-free therapy for inflammatory diseases: opportunities and challenges. Recent Adv Inflamm Allergy Drug Discov 15:5\u20138. https:\/\/doi.org\/10.2174\/2772270816666211220152218","journal-title":"Recent Adv Inflamm Allergy Drug Discov"},{"key":"10522_CR78","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/01652176.2022.2145620","volume":"42","author":"K Sharun","year":"2022","unstructured":"Sharun K, Muthu S, Mankuzhy PD et al (2022) Cell-free therapy for canine osteoarthritis: current evidence and prospects. Vet Q 42:224\u2013230. https:\/\/doi.org\/10.1080\/01652176.2022.2145620","journal-title":"Vet Q"},{"key":"10522_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s11259-024-10398-w","author":"K Sharun","year":"2024","unstructured":"Sharun K, Banu SA, Pawde AM et al (2024) Minimal criteria for reporting mesenchymal stem cells in veterinary regenerative medicine. Vet Res Commun. https:\/\/doi.org\/10.1007\/s11259-024-10398-w","journal-title":"Vet Res Commun"},{"key":"10522_CR80","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13287-017-0577-3","volume":"8","author":"AB Sherman","year":"2017","unstructured":"Sherman AB, Gilger BC, Berglund AK, Schnabel LV (2017) Effect of bone marrow-derived mesenchymal stem cells and stem cell supernatant on equine corneal wound healing in vitro. Stem Cell Res Ther 8:120. https:\/\/doi.org\/10.1186\/s13287-017-0577-3","journal-title":"Stem Cell Res Ther"},{"key":"10522_CR81","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/14712598.2023.2175605","volume":"23","author":"M Soleimani","year":"2023","unstructured":"Soleimani M, Masoumi A, Momenaei B et al (2023) Applications of mesenchymal stem cells in ocular surface diseases: sources and routes of delivery. Expert Opin Biol Ther 23:509\u2013525. https:\/\/doi.org\/10.1080\/14712598.2023.2175605","journal-title":"Expert Opin Biol Ther"},{"key":"10522_CR82","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song N, Scholtemeijer M, Shah K (2020) Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol Sci 41:653\u2013664. https:\/\/doi.org\/10.1016\/j.tips.2020.06.009","journal-title":"Trends Pharmacol Sci"},{"key":"10522_CR83","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1463-5224.2008.00679.x","volume":"12","author":"AK Spiess","year":"2009","unstructured":"Spiess AK, Sapienza JS, Mayordomo A (2009) Treatment of proliferative feline eosinophilic keratitis with topical 1.5% cyclosporine: 35 cases. Vet Ophthalmol 12:132\u2013137. https:\/\/doi.org\/10.1111\/j.1463-5224.2008.00679.x","journal-title":"Vet Ophthalmol"},{"issue":"1","key":"10522_CR84","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/vop.12371","volume":"19 Suppl","author":"J Stiles","year":"2016","unstructured":"Stiles J, Coster M (2016) Use of an ophthalmic formulation of megestrol acetate for the treatment of eosinophilic keratitis in cats. Vet Ophthalmol 19 Suppl(1):86\u201390. https:\/\/doi.org\/10.1111\/vop.12371","journal-title":"Vet Ophthalmol"},{"key":"10522_CR85","doi-asserted-by":"publisher","first-page":"e0263141","DOI":"10.1371\/journal.pone.0263141","volume":"17","author":"C Torsahakul","year":"2022","unstructured":"Torsahakul C, Israsena N, Khramchantuk S et al (2022) Bio-fabrication of stem-cell-incorporated corneal epithelial and stromal equivalents from silk fibroin and gelatin-based biomaterial for canine corneal regeneration. PLoS ONE 17:e0263141. https:\/\/doi.org\/10.1371\/journal.pone.0263141","journal-title":"PLoS ONE"},{"key":"10522_CR86","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5500\/wjt.v4.i3.196","volume":"4","author":"S-Y Tsai","year":"2014","unstructured":"Tsai S-Y, Huang Y-C, Chueh L-L et al (2014) Intra-articular transplantation of porcine adipose-derived stem cells for the treatment of canine osteoarthritis: a pilot study. World J Transpl 4:196\u2013205. https:\/\/doi.org\/10.5500\/wjt.v4.i3.196","journal-title":"World J Transpl"},{"key":"10522_CR87","doi-asserted-by":"publisher","unstructured":"Villatoro AJ, Fern\u00e1ndez V, Claros S et al (2015) Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model. BioMed Res Int 2015:527926. https:\/\/doi.org\/10.1155\/2015\/527926","DOI":"10.1155\/2015\/527926"},{"key":"10522_CR88","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12917-018-1413-4","volume":"14","author":"AJ Villatoro","year":"2018","unstructured":"Villatoro AJ, Claros S, Fern\u00e1ndez V et al (2018a) Safety and efficacy of the mesenchymal stem cell in feline eosinophilic keratitis treatment. BMC Vet Res 14:116. https:\/\/doi.org\/10.1186\/s12917-018-1413-4","journal-title":"BMC Vet Res"},{"key":"10522_CR89","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/vr.104867","volume":"183","author":"AJ Villatoro","year":"2018","unstructured":"Villatoro AJ, Hermida-Prieto M, Fern\u00e1ndez V et al (2018) Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safety. Vet Rec 183:654. https:\/\/doi.org\/10.1136\/vr.104867","journal-title":"Vet Rec"},{"key":"10522_CR90","doi-asserted-by":"publisher","first-page":"115206","DOI":"10.1016\/j.biopha.2023.115206","volume":"165","author":"M Wang","year":"2023","unstructured":"Wang M, Li Y, Wang H et al (2023) Corneal regeneration strategies: from stem cell therapy to tissue engineered stem cell scaffolds. Biomed Pharmacother Biomedecine Pharmacother 165:115206. https:\/\/doi.org\/10.1016\/j.biopha.2023.115206","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"10522_CR91","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12917-022-03303-7","volume":"18","author":"L-N Wei","year":"2022","unstructured":"Wei L-N, Wu C-H, Lin C-T, Liu I-H (2022) Topical applications of allogeneic adipose-derived mesenchymal stem cells ameliorate the canine keratoconjunctivitis sicca. BMC Vet Res 18:217. https:\/\/doi.org\/10.1186\/s12917-022-03303-7","journal-title":"BMC Vet Res"},{"key":"10522_CR92","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cvsm.2007.12.002","volume":"38","author":"DL Williams","year":"2008","unstructured":"Williams DL (2008) Immunopathogenesis of keratoconjunctivitis sicca in the dog. Vet Clin North Am Small Anim Pract 38:251\u2013268. https:\/\/doi.org\/10.1016\/j.cvsm.2007.12.002. (vi)","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10522_CR93","doi-asserted-by":"publisher","unstructured":"Wright A, Arthaud-Day ML, Weiss ML (2021) Therapeutic use of mesenchymal stromal cells: the need for inclusive characterization guidelines to accommodate all tissue sources and species. Front Cell Dev Biol 9. https:\/\/doi.org\/10.3389\/fcell.2021.632717","DOI":"10.3389\/fcell.2021.632717"},{"key":"10522_CR94","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/ma17010086","volume":"17","author":"KY Wu","year":"2023","unstructured":"Wu KY, Akbar D, Giunta M et al (2023) Hydrogels in Ophthalmology: Novel Strategies for Overcoming Therapeutic challenges. Mater Basel Switz 17:86. https:\/\/doi.org\/10.3390\/ma17010086","journal-title":"Mater Basel Switz"},{"key":"10522_CR95","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2460\/ajvr.82.6.487","volume":"82","author":"VK Yang","year":"2021","unstructured":"Yang VK, Meola DM, Davis A et al (2021) Intravenous administration of allogeneic Wharton jelly-derived mesenchymal stem cells for treatment of dogs with congestive heart failure secondary to myxomatous mitral valve disease. Am J Vet Res 82:487\u2013493. https:\/\/doi.org\/10.2460\/ajvr.82.6.487","journal-title":"Am J Vet Res"},{"key":"10522_CR96","doi-asserted-by":"publisher","first-page":"e30842","DOI":"10.1371\/journal.pone.0030842","volume":"7","author":"L Yao","year":"2012","unstructured":"Yao L, Li Z, Su W et al (2012) Role of mesenchymal stem cells on Cornea Wound Healing Induced by Acute Alkali burn. PLoS ONE 7:e30842. https:\/\/doi.org\/10.1371\/journal.pone.0030842","journal-title":"PLoS ONE"},{"key":"10522_CR97","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/sj.eye.6701913","volume":"20","author":"J Ye","year":"2006","unstructured":"Ye J, Yao K, Kim JC (2006) Mesenchymal stem cell transplantation in a rabbit corneal alkali burn model: engraftment and involvement in wound healing. Eye Lond Engl 20:482\u2013490. https:\/\/doi.org\/10.1038\/sj.eye.6701913","journal-title":"Eye Lond Engl"},{"key":"10522_CR98","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4252\/wjsc.v12.i3.178","volume":"12","author":"B Yu","year":"2020","unstructured":"Yu B, Li X-R, Zhang X-M (2020) Mesenchymal stem cell-derived extracellular vesicles as a new therapeutic strategy for ocular diseases. World J Stem Cells 12:178\u2013187. https:\/\/doi.org\/10.4252\/wjsc.v12.i3.178","journal-title":"World J Stem Cells"},{"key":"10522_CR99","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.rvsc.2021.09.015","volume":"141","author":"S Zacharias","year":"2021","unstructured":"Zacharias S, Welty MB, Sand TT, Black LL (2021) Impact of allogeneic feline uterine-derived mesenchymal stromal cell intravenous treatment on renal function of nephrectomized cats with chronic kidney disease. Res Vet Sci 141:33\u201341. https:\/\/doi.org\/10.1016\/j.rvsc.2021.09.015","journal-title":"Res Vet Sci"},{"key":"10522_CR100","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-021-01037-x","volume":"14","author":"T Zhou","year":"2021","unstructured":"Zhou T, Yuan Z, Weng J et al (2021) Challenges and advances in clinical applications of mesenchymal stromal cells. J Hematol OncolJ Hematol Oncol 14:24. https:\/\/doi.org\/10.1186\/s13045-021-01037-x","journal-title":"J Hematol OncolJ Hematol Oncol"}],"container-title":["Veterinary Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-024-10522-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11259-024-10522-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-024-10522-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T18:06:29Z","timestamp":1730829989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11259-024-10522-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10522"],"URL":"https:\/\/doi.org\/10.1007\/s11259-024-10522-w","relation":{},"ISSN":["0165-7380","1573-7446"],"issn-type":[{"value":"0165-7380","type":"print"},{"value":"1573-7446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"23 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors declare that no commercial or financial relationships exist that could, in any way, lead to a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}